share_log

金活医药集团发盈喜 预期中期溢利增加约35%至40%

Jinhuo Pharmaceutical Group's Fa Yingxi expects medium-term profit to increase by about 35% to 40%

新浪港股 ·  Aug 2, 2023 20:18

Jinhuo Pharmaceutical Group (01110) announced that the group profit for the six months ended June 30, 2023 is expected to increase by about 35% to 40% compared with the group profit of RMB 35.1 million in the first half of 2022.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment